Annual Revenue
$258.21 M
+$104.14 M+67.59%
31 December 2023
Summary:
ADMA Biologics annual revenue is currently $258.21 million, with the most recent change of +$104.14 million (+67.59%) on 31 December 2023. During the last 3 years, it has risen by +$216.00 million (+511.60%). ADMA annual revenue is now at all-time high.ADMA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$119.84 M
+$12.65 M+11.80%
30 September 2024
Summary:
ADMA Biologics quarterly revenue is currently $119.84 million, with the most recent change of +$12.65 million (+11.80%) on 30 September 2024. Over the past year, it has increased by +$52.56 million (+78.13%). ADMA quarterly revenue is now at all-time high.ADMA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$382.81 M
+$52.56 M+15.92%
30 September 2024
Summary:
ADMA Biologics TTM revenue is currently $382.81 million, with the most recent change of +$52.56 million (+15.92%) on 30 September 2024. Over the past year, it has increased by +$148.52 million (+63.39%). ADMA TTM revenue is now at all-time high.ADMA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.6% | +78.1% | +63.4% |
| 3 y3 years | +511.6% | +479.5% | +458.7% |
| 5 y5 years | +1420.2% | +1559.3% | +1691.5% |
ADMA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +511.6% | at high | +479.5% | at high | +458.7% |
| 5 y | 5 years | at high | +1420.2% | at high | +1559.3% | at high | +1691.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
ADMA Biologics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $119.84 M(+11.8%) | $382.81 M(+15.9%) |
| June 2024 | - | $107.19 M(+30.9%) | $330.25 M(+16.6%) |
| Mar 2024 | - | $81.88 M(+10.8%) | $283.18 M(+9.7%) |
| Dec 2023 | $258.21 M(+67.6%) | $73.90 M(+9.9%) | $258.22 M(+10.2%) |
| Sept 2023 | - | $67.28 M(+11.9%) | $234.29 M(+12.6%) |
| June 2023 | - | $60.12 M(+5.6%) | $208.11 M(+14.4%) |
| Mar 2023 | - | $56.91 M(+13.9%) | $181.89 M(+18.0%) |
| Dec 2022 | $154.08 M(+90.4%) | $49.98 M(+21.6%) | $154.08 M(+18.1%) |
| Sept 2022 | - | $41.09 M(+21.2%) | $130.48 M(+18.5%) |
| June 2022 | - | $33.91 M(+16.5%) | $110.07 M(+17.1%) |
| Mar 2022 | - | $29.10 M(+10.3%) | $94.00 M(+16.1%) |
| Dec 2021 | $80.94 M(+91.7%) | $26.38 M(+27.6%) | $80.94 M(+18.1%) |
| Sept 2021 | - | $20.68 M(+16.0%) | $68.52 M(+17.9%) |
| June 2021 | - | $17.83 M(+11.1%) | $58.11 M(+20.9%) |
| Mar 2021 | - | $16.05 M(+15.0%) | $48.07 M(+13.9%) |
| Dec 2020 | $42.22 M(+43.9%) | $13.96 M(+35.8%) | $42.22 M(+4.8%) |
| Sept 2020 | - | $10.28 M(+32.0%) | $40.30 M(+8.2%) |
| June 2020 | - | $7.79 M(-23.6%) | $37.25 M(+3.4%) |
| Mar 2020 | - | $10.20 M(-15.3%) | $36.02 M(+22.7%) |
| Dec 2019 | $29.35 M(+72.8%) | $12.04 M(+66.7%) | $29.35 M(+37.3%) |
| Sept 2019 | - | $7.22 M(+10.1%) | $21.37 M(+16.3%) |
| June 2019 | - | $6.56 M(+85.9%) | $18.38 M(+11.6%) |
| Mar 2019 | - | $3.53 M(-13.0%) | $16.47 M(-3.0%) |
| Dec 2018 | $16.99 M | $4.06 M(-4.1%) | $16.99 M(-31.9%) |
| Sept 2018 | - | $4.23 M(-9.2%) | $24.93 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $4.66 M(+15.2%) | $25.43 M(+5.2%) |
| Mar 2018 | - | $4.04 M(-66.3%) | $24.17 M(+6.2%) |
| Dec 2017 | $22.76 M(+113.5%) | $12.00 M(+153.8%) | $22.76 M(+61.6%) |
| Sept 2017 | - | $4.73 M(+39.1%) | $14.09 M(+14.6%) |
| June 2017 | - | $3.40 M(+29.3%) | $12.29 M(+10.1%) |
| Mar 2017 | - | $2.63 M(-21.0%) | $11.17 M(+4.7%) |
| Dec 2016 | $10.66 M(+48.5%) | $3.33 M(+13.3%) | $10.66 M(+8.3%) |
| Sept 2016 | - | $2.94 M(+29.3%) | $9.85 M(+12.4%) |
| June 2016 | - | $2.27 M(+7.0%) | $8.76 M(+12.3%) |
| Mar 2016 | - | $2.12 M(-15.5%) | $7.80 M(+8.6%) |
| Dec 2015 | $7.18 M(+21.3%) | $2.51 M(+35.6%) | $7.18 M(+16.6%) |
| Sept 2015 | - | $1.85 M(+41.4%) | $6.15 M(+8.6%) |
| June 2015 | - | $1.31 M(-12.9%) | $5.67 M(-3.3%) |
| Mar 2015 | - | $1.50 M(+1.0%) | $5.86 M(-1.0%) |
| Dec 2014 | $5.92 M(+92.8%) | $1.49 M(+9.0%) | $5.92 M(+21.9%) |
| Sept 2014 | - | $1.37 M(-9.0%) | $4.85 M(+5.6%) |
| June 2014 | - | $1.50 M(-3.9%) | $4.59 M(+19.7%) |
| Mar 2014 | - | $1.56 M(+268.1%) | $3.84 M(+25.0%) |
| Dec 2013 | $3.07 M(+174.4%) | $424.00 K(-61.7%) | $3.07 M(-3.1%) |
| Sept 2013 | - | $1.11 M(+49.0%) | $3.17 M(+30.9%) |
| June 2013 | - | $743.30 K(-6.3%) | $2.42 M(+26.9%) |
| Mar 2013 | - | $792.90 K(+51.5%) | $1.91 M(+70.5%) |
| Dec 2012 | $1.12 M | $523.30 K(+45.2%) | $1.12 M(+88.0%) |
| Sept 2012 | - | $360.30 K(+56.6%) | $594.80 K(+153.6%) |
| June 2012 | - | $230.10 K(+5129.5%) | $234.50 K(+5229.5%) |
| Mar 2012 | - | $4400.00 | $4400.00 |
FAQ
- What is ADMA Biologics annual revenue?
- What is the all time high annual revenue for ADMA Biologics?
- What is ADMA Biologics annual revenue year-on-year change?
- What is ADMA Biologics quarterly revenue?
- What is the all time high quarterly revenue for ADMA Biologics?
- What is ADMA Biologics quarterly revenue year-on-year change?
- What is ADMA Biologics TTM revenue?
- What is the all time high TTM revenue for ADMA Biologics?
- What is ADMA Biologics TTM revenue year-on-year change?
What is ADMA Biologics annual revenue?
The current annual revenue of ADMA is $258.21 M
What is the all time high annual revenue for ADMA Biologics?
ADMA Biologics all-time high annual revenue is $258.21 M
What is ADMA Biologics annual revenue year-on-year change?
Over the past year, ADMA annual revenue has changed by +$104.14 M (+67.59%)
What is ADMA Biologics quarterly revenue?
The current quarterly revenue of ADMA is $119.84 M
What is the all time high quarterly revenue for ADMA Biologics?
ADMA Biologics all-time high quarterly revenue is $119.84 M
What is ADMA Biologics quarterly revenue year-on-year change?
Over the past year, ADMA quarterly revenue has changed by +$52.56 M (+78.13%)
What is ADMA Biologics TTM revenue?
The current TTM revenue of ADMA is $382.81 M
What is the all time high TTM revenue for ADMA Biologics?
ADMA Biologics all-time high TTM revenue is $382.81 M
What is ADMA Biologics TTM revenue year-on-year change?
Over the past year, ADMA TTM revenue has changed by +$148.52 M (+63.39%)